TABLE 1.
Characteristic | Total (N=1257) | Nerve sparing RH (n=883) |
Non-nerve sparing RH (n=374) |
P value |
---|---|---|---|---|
Age (y) | .090 | |||
≤45 | 616 (49.0) | 419 (47.5) | 197 (52.7) | |
>45 | 641 (51.0) | 464 (52.5) | 177 (47.3) | |
Pathologic stage | <.0001 | |||
IB1 | 1186 (94.4) | 846 (95.8) | 340 (90.9) | |
IIA1 | 71 (5.6) | 37 (4.2) | 34 (9.1) | |
Grade | .259 | |||
1 | 120 (9.5) | 92 (10.4) | 28 (7.5) | |
2 | 877 (69.8) | 612 (69.3) | 265 (70.9) | |
3 | 260 (20.7) | 179 (20.3) | 81 (21.7) | |
LVSI | <.0001 | |||
No | 600 (47.7) | 403 (45.6) | 197 (52.7) | |
Yes | 432 (34.4) | 291 (33.0) | 141 (37.7) | |
Unknown | 225 (17.9) | 189 (21.4) | 36 (9.6) | |
Histology | .291a | |||
Squamous | 823 (65.5) | 566 (64.1) | 257 (68.7) | |
Adenocarcinoma | 348 (27.7) | 253 (28.7) | 95 (25.4) | |
Adenosquamous | 67 (5.3) | 50 (5.7) | 17 (4.5) | |
Others | 19 (1.5) | 14 (1.5) | 5 (1.4) | |
Diameter | <.0001 | |||
≤20 mm | 712 (56.6) | 535 (60.6) | 177 (47.3) | |
21–40 mm | 545 (43.4) | 348 (39.4) | 197 (52.7) | |
Adjuvant therapy | .633 | |||
No | 909 (72.3) | 642 (72.7) | 267 (71.4) | |
Yes | 348 (27.7) | 241 (27.3) | 107 (28.6) |
LVSI, lymphovascular space invasion; RH, radical hysterectomy.
The test was performed on squamous vs adenocarcinoma vs adenosquamous.